Nissay Asset Management Corp Royalty Pharma PLC Transaction History

Nissay Asset Management Corp

$16.7 Billion
Q2 2025

A detailed history of Nissay Asset Management Corp transactions in Royalty Pharma PLC stock. As of the latest transaction made, Nissay Asset Management Corp holds 48,506 shares of RPRX stock, worth $1.76 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

48,506

Previous 48,677 0.35%

Holding current value

$1.76 Million

Previous $1.52 Million 15.31%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$30.85 - $36.14 $5,275 - $6,179	-171 Reduced 0.35%	48,506 $1.75 Million
Q1 2025 May 15, 2025	BUY	$25.75 - $33.86 $5,047 - $6,636	196 Added 0.4%	48,677 $1.52 Million
Q4 2024 Feb 14, 2025	BUY	$24.28 - $28.39 $8,473 - $9,908	349 Added 0.73%	48,481 $1.24 Million
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $52,054 - $59,447	2,031 Added 4.41%	48,132 $1.36 Million
Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $45,639 - $51,966	1,738 Added 3.92%	46,101 $1.22 Million
Q1 2024 May 15, 2024	BUY	$27.46 - $31.33 $16,585 - $18,923	604 Added 1.38%	44,363 $1.35 Million
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $70,583 - $78,689	2,693 Added 6.56%	43,759 $1.23 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $49,132 - $58,711	1,871 Added 4.77%	41,066 $1.11 Million
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $66,156 - $81,711	2,235 Added 6.05%	39,195 $1.2 Million
Q1 2023 May 15, 2023	SELL	$32.77 - $39.4 $41,093 - $49,407	-1,254 Reduced 3.28%	36,960 $1.33 Million
Q4 2022 Feb 14, 2023	SELL	$39.17 - $44.04 $12,573 - $14,136	-321 Reduced 0.83%	38,214 $1.51 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $68,115 - $76,262	1,708 Added 4.64%	38,535 $1.55 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $3,340 - $3,935	89 Added 0.24%	36,827 $1.55 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $38,321 - $43,416	1,023 Added 2.86%	36,738 $1.43 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $589,484 - $712,007	16,761 Added 88.43%	35,715 $1.42 Million
Q3 2021 Nov 10, 2021	BUY	$36.14 - $42.24 $29,779 - $34,805	824 Added 4.54%	18,954 $685,000
Q2 2021 Aug 13, 2021	BUY	$39.85 - $46.63 $8,009 - $9,372	201 Added 1.12%	18,130 $743,000
Q1 2021 May 11, 2021	BUY	$42.34 - $52.82 $214,071 - $267,057	5,056 Added 39.28%	17,929 $782,000
Q4 2020 Feb 08, 2021	BUY	$36.12 - $50.05 $464,972 - $644,293	12,873 New	12,873 $644,000

Others Institutions Holding RPRX

# of Institutions

497

Shares Held

307M

Call Options Held

1.99M

Put Options Held

384K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.9B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.

Account

Nissay Asset Management Corp Royalty Pharma PLC Transaction History